DE:LWB Stock Latest News
Company AnnouncementsMesoblast Receives Deloitte Leadership & Enterprise Growth Award12h ago
Company AnnouncementsMesoblast Showcased at ASX Investor Day4d ago
Company AnnouncementsMesoblast Investor Day Presentation Includes Risk Disclosures4d ago
Company AnnouncementsMesoblast Notice Discloses Director’s Indirect Shareholding1w ago
Company AnnouncementsMesoblast Reports All Annual Meeting Resolutions Carried1w ago
Company AnnouncementsMesoblast Reports RYONCIL Sales as Company Shifts Toward Commercial Execution1w ago
Company AnnouncementsMesoblast’s Final Director Interest Notice for Eric Rose1w ago
Company AnnouncementsMesoblast Highlights Ryoncil’s Role in Pediatric Graft-Versus-Host Disease2w ago
Company AnnouncementsMesoblast Announces Board Changes Following Ryoncil Launch2w ago
Company AnnouncementsState Street Entities Exit Substantial Holder Position in Mesoblast3w agoCompany AnnouncementsMesoblast Files Updated Corporate Governance Statement and ASX Appendix 4G1M ago
Company AnnouncementsState Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold1M ago
Company AnnouncementsMesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches1M ago
Company AnnouncementsState Street Group Ceases to Be Substantial Holder in Mesoblast1M ago
Company AnnouncementsMesoblast revenue surges on RYONCIL launch as late‑stage pipeline advances2M ago





